SCHEMBL4429397

SCHEMBL4429397

Nc1sc2cc3[nH]ccc3cc2c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 1/20 0.41
USP2 O75604 1/20 0.41
GAA P10253 1/20 0.41
ALOX15 P16050 1/20 0.41
RAD51 Q06609 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GPR84 Q9NQS5 1/20 0.38
F2 P00734 1/20 0.36
GUSB P08236 3/20 0.35
ENPP2 Q13822 2/20 0.34
CSNK2A1 P68400 1/20 0.34
KIF11 P52732 1/20 0.34
MAOB P27338 1/20 0.34
AHR P35869 6/20 0.33
NR4A2 P43354 2/20 0.33
CYP2A6 P11509 1/20 0.33
CMA1 P23946 1/20 0.33
F7 P08709 1/20 0.33
LTA4H P09960 1/20 0.33
F3 P13726 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4429377 0.83 GPR84 (0.40) TYRUSP2GAAALOX15RAD51
SCHEMBL4423427 0.81 TYR (0.41) TYRUSP2GAAALOX15RAD51
SCHEMBL20427261 0.70 GPR3 (0.48) TYRUSP2GAAALOX15RAD51
SCHEMBL4424494 0.70 GPR84 (0.40) TYRUSP2GAAALOX15RAD51
SCHEMBL4417262 0.70 TYR (0.43) TYRUSP2GAAALOX15RAD51
SCHEMBL4418834 0.69 TYR (0.46) TYRUSP2GAAALOX15RAD51
SCHEMBL4417259 0.69 GPR84 (0.42) TYRUSP2GAAALOX15RAD51
SCHEMBL4419227 0.68 DYRK1A (0.35) CYP2A6KDM4EALDH1A1HPGDHSD17B10
SCHEMBL15984707 0.66 TYR (0.50) TYRUSP2GAAALOX15RAD51
SCHEMBL4430331 0.66 TYR (0.46) TYRUSP2GAAALOX15RAD51

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351266-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-04-01 US claimed
US-20050193504-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-09-08 US claimed
EP-1720615-B1 COSMETIC HAIR DYEING COMPOSITIONS CONTAINING THEM AND USE THEREOF PROCTER & GAMBLE (US) 2009-12-30 EP disclosed
US-7468080-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-12-23 US disclosed
US-20080134450-A1 Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof WELLA OPERATIONS US, LLC 2008-06-12 US disclosed
US-7351266-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-04-01 US disclosed
EP-1720615-A1 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF The Procter and Gamble Company (US) 2006-11-15 EP disclosed
WO-2005087187-A1 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2005-09-22 WO disclosed
US-20050193504-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050193504-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, CKMT1A; CKMT1B, KRTCAP2 TYR 233/4885USP2 2400/4885GAA 3660/4885
US-20080134450-A1 Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof KRT18, CKMT1A; CKMT1B, KRTCAP2 TYR 233/4885USP2 2400/4885GAA 3660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.